ALBANY MOLECULAR RESEARCH INC·4

Feb 1, 4:08 PM ET

ALBANY MOLECULAR RESEARCH INC 4

4 · ALBANY MOLECULAR RESEARCH INC · Filed Feb 1, 2017

Insider Transaction Report

Form 4
Period: 2017-01-31
Hagen Steven R
VP Pharmaceutical Dev & Mfg
Transactions
  • Tax Payment

    Common Stock

    2017-01-31$18.11/sh531$9,61633,851 total
  • Tax Payment

    Common Stock

    2017-01-31$18.11/sh531$9,61634,382 total
Footnotes (1)
  • [F1]Consists of shares withheld by Albany Molecular Research, Inc. in order to satisfy the minimum tax withholding obligation of the reporting person.

Documents

1 file
  • 4
    doc4_4503.xmlPrimary

    PRIMARY DOCUMENT